KPV: Benefits, Dosage, Side Effects, and How to Get It in 2026

What is KPV?

KPV is a tripeptide made of three amino acids: lysine (K), proline (P), and valine (V). It is the C-terminal fragment of alpha-MSH (alpha-melanocyte-stimulating hormone), a naturally occurring hormone with anti-inflammatory activity.

KPV carries the anti-inflammatory action of the parent hormone in a much smaller, more stable molecule — small enough to be used orally, topically, or by injection.

Benefits and uses

What the research shows — the evidence base is anti-inflammatory and largely preclinical, which is the honest framing for KPV:

• Gut healing and inflammatory bowel conditions. The most-studied use. KPV has been studied in models of inflammatory bowel disease for its ability to calm intestinal inflammation and support healing of the gut lining.
• Immune modulation. It downregulates inflammatory signaling broadly, which is why it is studied as a general anti-inflammatory rather than for one tissue alone.
• Skin inflammation. Applied topically, KPV has been studied for inflammatory skin conditions and wound healing.

The gap between anecdote and human evidence is real. Most KPV data comes from cell and animal research; rigorous human clinical trials are limited. State that plainly rather than overselling.

How it works

KPV works inside the cell rather than only at a surface receptor. Once inside, it interferes with the NF-kB signaling pathway — the master switch the body uses to turn on inflammatory genes.

By downregulating that pathway, KPV reduces the production of inflammatory signals at the source. That intracellular mechanism is part of why it can be effective across the gut, the immune system, and the skin.

Dosage and administration

KPV is unusual among therapeutic peptides in that it is used by multiple routes — oral, topical, or subcutaneous injection — depending on the target.

Oral and topical forms are common for gut and skin uses; subcutaneous dosing is used for systemic anti-inflammatory effect. These are not official dosing guidelines — there is no FDA-approved KPV product — and dosing and route should be set by the prescribing provider.

For injectable use, reconstitution (mixing the lyophilized powder with bacteriostatic water) and drawing the right volume on an insulin syringe is where most people make errors.

Use the peptide dosage calculator to convert your target dose into syringe units for your vial size.

Side effects and safety

KPV has shown a favorable safety profile in research, consistent with its small size and its origin as a fragment of a natural hormone. Reported effects in human use are generally mild.

The honest caveat: long-term human safety data does not exist. Anyone using KPV should work with a provider and monitor liver enzymes and kidney function on a cycle.

Legal status and how to get it in 2026

This is the question most searchers actually have. The status changed this year:

• For several years KPV sat on the FDA's Section 503A Category 2 list, which effectively blocked compounding pharmacies from preparing it.
• On April 15, 2026 the FDA removed KPV (and 11 other peptides) from that Category 2 list.
• A Pharmacy Compounding Advisory Committee meeting on July 23–24, 2026 will evaluate whether KPV should be formally added to the authorized bulk-substances list compounding pharmacies can use.

Until that process completes, the cleanest legal route is a prescription filled by a licensed compounding pharmacy. Products sold online "for research use only" are not manufactured or quality-controlled for human use, and buying them carries both quality and legal risk.

Rite Aid is preparing compounded peptide consultations. Join the waitlist to claim 20% off your first KPV order when consultations and ordering open.

KPV in the healing stack

KPV is the anti-inflammatory addition to the recovery stack built around BPC-157 and TB-500.

Where BPC-157 drives local repair and angiogenesis and TB-500 supports systemic cell migration, KPV calms the inflammation that accompanies injury and gut irritation. For the broader protocol, compare all three healing and recovery peptides.

Blood work to track KPV

KPV doesn't have a single direct biomarker, so tracking focuses on the inflammation it's meant to reduce and on safety:

• hs-CRP — a sensitive inflammation marker; useful to see whether systemic inflammation is trending down.
• Comprehensive metabolic profile — liver enzymes and kidney function, the safety baseline for any peptide cycle.

Test before you start and again at 4–6 weeks.